Read + Share
Amedeo Smart
Independent Medical Education
Veneris JT, Matulonis UA, Liu JF, Konstantinopoulos PA, et al. Choosing wisely: Selecting PARP inhibitor combinations to promote anti-tumor immune responses beyond BRCA mutations. Gynecol Oncol 2020;156:488-497.PMID: 31630846
Email
LinkedIn
Facebook
Twitter
Privacy Policy